EL7.AI
StocksMedium•17 November 2026•
3 min read

OneMedNet Revenue Reaches $1.023 Million in Third Quarter, Up 478% Year Over Year

Key Facts

1OneMedNet's third-quarter revenue was $1.023 million, compared with $177 thousand a year earlier.
2Third-quarter revenue rose 478% year over year, an increase of $0.8 million.
3Revenue for the first nine months was $1.410 million, compared with $468 thousand in the corresponding period.
4The company posted a third-quarter net loss of $2.660 million, compared with $741 thousand a year earlier.
5The cash balance was $0.1 million, insufficient to fund operations for at least 12 months.

On November 17, OneMedNet reported results for the quarter ended September 30, recording revenue of $1.023 million, compared with $177 thousand in the corresponding quarter of 2025, according to its quarterly filing with the U.S. Securities and Exchange Commission. The figures represent a year-over-year increase of 478%, or $846 thousand, according to the company. OneMedNet attributed revenue growth to increased data delivery as it transitioned to a unified real-world data platform, improved customer adoption and higher delivery volumes. In the report, it said total revenue "increased by $0.8 million, or 478%." Cumulative revenue for the nine months ended September 30 was $1.410 million, compared with $468 thousand in the same period a year earlier.

The increase in cumulative revenue came from data delivery, which generated $1.410 million during the first nine months of 2026, compared with $363 thousand in the corresponding period of 2025. By contrast, subscription revenue fell from $105 thousand to zero, according to the report. This divergence reflects that the period's recorded growth depended on data delivery, while the company recorded no subscription revenue in the first nine months. OneMedNet had said in an initial statement issued on November 6 that third-quarter revenue was approximately $1 million. At the time, it estimated the increase at 242% compared with the previous quarter and 465% year over year, before the final report provided actual revenue and a 478% year-over-year comparison.

Despite the expansion in sales, gross margin remained negative, at negative $363 thousand in the third quarter, compared with negative $222 thousand in the corresponding quarter of 2025. The company posted a net loss of $2.660 million, compared with a loss of $741 thousand a year earlier. These figures show that higher revenue coincided with larger losses and a deeper negative gross margin, according to the quarterly results. Net cash used in operating activities was also $4.839 million during the first nine months of 2026, compared with $5.455 million in the same period of 2025. This provides a comparison of operating cash flows between the two periods, alongside the quarterly loss and gross margin.

The company warned that its cash balance of $137 thousand as of September 30 was insufficient to fund operations for at least 12 months. In the report, it said these circumstances "raise substantial doubt about the company's ability to continue as a going concern." Management said continuing and expanding operations would require raising additional working capital through the issuance of equity or debt. It also noted that an equity issuance could dilute existing shareholders. The liquidity warning makes financing part of the results context, after the company recorded a quarterly net loss and cash used in operating activities during the first nine months.

The fourth-quarter outlook previously announced by the company remains far above third-quarter revenue, at between $12 million and $14 million. OneMedNet linked these estimates to anticipated customer acceptance of data delivered by the end of the quarter, according to its outlook statement. It said the expected acceleration in delivery is tied to order timing and the infrastructure's ability to scale. The announced outlook therefore depends on customers completing acceptance of delivered data, as well as on order timing and the operating capacity cited in the statement. ONMD shares closed at $4.86 on November 16, according to EL7 data.

Open on chart